Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

17.04 -1.04 (-5.73%)
Streaming Delayed Price Updated: 3:34 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest... 
Via Benzinga
Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Another Heavy News Day
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
A Heavy News Day And Crypto
Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today. 
Via Talk Markets
Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript
TEVA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT
Teva Pharmaceutical Industries Ltd’s (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers,... 
Via Benzinga
Exposures COVID-19
What's Behind Teva's Mixed Q1 Results
Increased competition for several of its top products continued to affect the drugmaker's performance in Q1. 
Via The Motley Fool
Recap: Teva Pharmaceutical Q1 Earnings
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) rose 1.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 17.11... 
Via Benzinga
Markets Are Paralyzed Ahead Of Two-Day FOMC Meeting
Strong reports from major U.S. companies are pushing indices higher. But the market is showing low volatility as investors took a temporary pause after a proposal from Joe Biden to raise taxes on... 
Via Talk Markets
Teva Earnings Top But Drugmaker's Sales Just Miss Views
Teva earnings fell less than expected but sales came in slightly below estimates for the drug giant. Teva stock was little changed. 
Via Investor's Business Daily
Teva Reports First Quarter 2021 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Earnings Scheduled For April 28, 2021
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco... 
Via Benzinga
Teva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
London Cancel
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon. 
Via Talk Markets
Exposures COVID-19
This Risk Might Shock Anyone Holding Johnson & Johnson Stock
Lawsuits delayed by the pandemic could give shareholders a nasty surprise in the months ahead. 
Via The Motley Fool
Topics Death Lawsuit
Exposures Death Financial Legal
Teva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
Earth Day
Once again the exchanges are unsure if they want to go up or down. 
Via Talk Markets
Gold Is Back
Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs. 
Via Talk Markets
Robots
Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs. 
Via Talk Markets
New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Reduction of Migraine Burden Presented at 2021 American Academy of Neurology Virtual Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Currency Manipulation
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53. 
Via Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at Upcoming 2021 American Academy of Neurology Virtual Annual Meeting, Highlighting Teva’s Ongoing Commitment to Neurology
From Teva Pharmaceutical Industries Limited
Via Business Wire
Stunning Market Debut
Wednesday brought a zip into the accounts of many financial stocks thanks to a boom result from Goldman Sachs GS, which boosted its competitors' prices. 
Via Talk Markets
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ... 
Via Benzinga
Exposures COVID-19
Electric Cancer Cure
Most US stocks were down on fear of inflation and financial risks but then rose after lunch. 
Via Talk Markets
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /... 
Via Benzinga
Exposures COVID-19
Heavy News Day - Cheats
US job losses were up 744,000 vs a forecast of 694,000. 
Via Talk Markets
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s (NASDAQ: AZN) and... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.